The Event of the Year
AHA Scientific Sessions 2024 invites you to Chicago. Join us November 16–18 and the Pre-Sessions Symposia & Early Career Day November 15. Reconnect with colleagues, experience breakthrough basic, clinical, and population science updates and advance your career as we celebrate the accomplishments and innovations in cardiovascular and stroke science and medicine. Be sure to mark these can’t-miss sessions featuring the most relevant topics and controversies in cardiovascular health on your meeting itinerary.
Notable Sessions
- Scientific Sessions 2024 Opening Session
- Presidential Session and Conner Lecture
- 2024 Update on CV Disorders that Disproportionately Affect Women
- Annual Dr. Nanette K. Wenger Research Goes Red® Award for Best Scientific Article on Cardiovascular Disease and Stroke in Women
- Distinguished Scientist Lecture Session
- Environmental Crisis Exposome: Reshaping the landscape of CV Basic Research and Health Care
- Fellowship of the Ring: Atrial Fibrillation & Heart Failure, a Collaborative Journey Through the New Middle Earth
- Gene Therapy in the Cardiology Clinic: Ready for Prime Time?
- Generative AI in Cardiovascular Health: A Transformative Force
- GLP-1RAs and Beyond: Incretin Analogues and a New Frontier in Cardiovascular Therapeutics
- Health Technologies Impact on Cardiology Over the Last 100 Years and What the Future Holds
- Henning Lecture Session: Non-Traditional Risk Factors & Biomarkers of Peripheral Arterial Disease
- Making Great Strides: Our Journey in the Treatment of Acute Myocardial Infarction
- Nobel Laureate Lecture Session
- Paul Dudley White International Lecture and Session
- Closing Session: Towards the Future: The Next 100 Years in Cardiovascular Science and Medicine
More than 300 educational sessions available OnDemand through October 2025
CE and MOC credits available
Featured Faculty
Every year, Scientific Sessions prides itself on having the top experts from around the world to discuss key information and the latest updates in the fields. Cardiovascular science and healthcare masters joining this year’s Sessions:
- E. Dale Abel MD PhD
- Demilade Adedinsewo, MD, MPH
- Eric Adler, MD
- Michelle A. Albert, MD, MPH, FACC, FAHA
- Kevin M. Alexander, MD
- Matthew Allison, MD, MPH, FAHA
- Amrut Ambardekar, MD, FAHA
- Jason G. Andrade MD FRCPC
- Rima Arnaout, MD, FAIMBE, FASE
- Shipra Arya MD, SM, FACS, DFSVS
- Folkert W. Asselbergs, MD, PhD, FESC
- Ivor Benjamin, MD, FAHA, FACC
- Katie Berlacher, MD, MS
- Beutler Bruce, MD
- Kirsten Bibbins-Domingo, PhD, MD, MAS
- Biykem Bozkurt, MD, FAHA, FACC, FHFSA
- Barbara Casadei, MD, Dphil, FRCP, FMedSci, FESC
- Yabing Chen, PhD, MBA, FAHA
- Joanna Chikwe, MD, FRCS, FAHA
- Mina K. Chung, MD, FAHA
- Keith Churchwell, MD, FACC, FACP, FAHA
- William Cornwell, MD
- Thais Coutinho, MD
- Marina Cuchel, MD, PhD
- Victoria Delgado, MD, PhD, FESC
- Mark Drazner, MD, MSc, FAHA
- Jane E. Freedman, MD, FAHA
- Jessica Golbus, MD, MS, FAHA
- Rakesh Gopinathannair, MD, MA, FAHA
- Scott Gordon, PhD
- Martha Gulati, MD, MS, FACC, FAHA, FASPC, FESC
- Janet Han, MD
- Robert A. Harrington, MD, FAHA
- Adam Helms, MD, MS
- Bertha Hidalgo, PhD, MPH
- Alice K. Jacobs, MD, FACC, FAHA, MSCAI
- Ania Jastreboff, MD, PhD
- James Jennings
- Steven P. Jones, PhD, FAHA
- Joel D. Kaufman, MD, MPH, FAHA
- Amit Khera, MD, MSc, FAHA, FACC, FASPC
- Rohan Khera, MD, MS, FAHA, FACC
- Marlys L. Koschinsky, PhD FAHA FRSC
- Natalia Linos, MSc, ScD
- Michael V. McConnell, MD, MSEE, FAHA
- John JV McMurray MD FESC, FACC, FAHA
- Elizabeth M. McNally, MD, PhD
- Venu Menon, MD, FAHA
- Faith Elise Metlock, PhDc, RN
- Erin D. Michos, MD, FAHA
- Jennifer H. Mieres, MD, FACC, FAHA
- Jagat Narula, MD, PhD, FAHA
- Sandeep Nathan, MD, MS
- Ana Navas-Acien, MD, PhD, MPH
- Chiadi Ndumele, MD, PhD, MHSc
- Adam Nelson, MBBS, PhD
- Emily O’Brien, MS, PhD
- Victoria Parikh, MD
- Annette Peters, DSc, FISEE
- Eric D. Peterson, MD, MPH
- Daniel Pineiro, MD, MACC, FAHA
- Janet T. Powell, MD, PhD, FRCPath
- Tiffany M. Powell-Wiley MD, MPH, FAHA, FABMR
- Richard E. Pratley, MD
- Sanjay Rajagopalan, MD, FACC FAHA
- Shiv Rao, MD
- Harmony Reynolds, MD
- Aya Saito, MD, PhD
- Sigrid Sandner, MD, MS
- Naveed Sattar, MD, PhD
- Rashmee Shah, MD, MS
- Lee Schwamm, MD
- Silvi Shah, MD, MS
- Garima Sharma, MD, FAHA
- Kavita Sharma, MD
- Christian Sohns, MD
- Jacqueline Tamis-Holland, MD
- Pam R. Taub, MD FACC, FASPC
- Phyllis Thangaraj, MD, PhD
- Christina Theodoris, MD, PhD
- Rebecca C. Thurston, PhD, FABMR, FAPS
- Philip S. Tsao, PhD, FAHA
- Sotirios Tsimikas, MD, FACC, FAHA
- Katherine R. Tuttle, MD, FASN, FACP, FNKF
- Marysia S. Tweet, MD, MS
- Renu Virmani, MD, FACC
- Paul J. Wang, MD, FAHA
- Hugh Watkins MD, PhD
- Janet Wright, MD
- Christina D. Yarrington, MD FACOG
- Quentin R. Youmans, MD, MSc, FACC
- Laura Young, MD, FSCAI
Late-Breaking Science
Leading researchers will reveal the results of high impact science from clinical registries, observational studies and randomized clinical trials.
Pre-Sessions Symposia and Early Career Day
Early Career
The AHA is committed to the next generation of clinicians and researchers by offering programs to facilitate your career growth and development. If you are a student, trainee, fellow, or early in your career, this is designed for you.
Congenital Heart Disease and Pediatric Cardiology Symposium
This program will focus on congenital and pediatric cardiology, including a showcase of distinguished AHA-supported congenital/pediatric cardiovascular researchers, preventive cardiology, including strategies for proactive practice change, closing gaps in care, and collaboration to prevent cardiovascular disease in children, and a reflection on the American Heart Association’s century-long journey in pediatric and congenital heart care, featuring esteemed speakers.
Heart/Kidney Symposium
This program will explore the epidemiology, pathophysiology, and treatment strategies for three key areas in nephrology, including atherosclerotic vascular disease in advanced chronic kidney disease (CKD), atrial fibrillation in the context of advanced CKD, and hypertension and chronic kidney disease, with international experts discussing the latest developments in these areas.
QCOR at Sessions
The QCOR at Scientific Sessions 2024 is a 1-day program that will be of interest to clinicians, researchers, medical students and trainees, nurses, pharmacists, administrators, healthcare and managed care professionals, policymakers, and other professionals interested in the quality of care and outcomes research in cardiovascular disease and stroke. The program begins on Friday, November 15, 2024, at 8 a.m. and ends at 5 p.m.
International Symposium
This symposium will bring together AHA’s international partners and collaborators to:
- Learn about AHA’s 2nd Century priorities to improve cardiovascular and brain health internationally.
- Share global perspectives and opportunities to engage and find solutions through research, evidenced based quality care, and system-wide approaches for improved health from patient to population.
Late-Breaking Science
Leading researchers will reveal the results of high impact science from clinical registries, observational studies and randomized clinical trials.
Pre-Sessions Symposia and Early Career Day
Early Career
The AHA is committed to the next generation of clinicians and researchers by offering programs to facilitate your career growth and development. If you are a student, trainee, fellow, or early in your career, this is designed for you.
Congenital Heart Disease and Pediatric Cardiology Symposium
This program will focus on congenital and pediatric cardiology, including a showcase of distinguished AHA-supported congenital/pediatric cardiovascular researchers, preventive cardiology, including strategies for proactive practice change, closing gaps in care, and collaboration to prevent cardiovascular disease in children, and a reflection on the American Heart Association’s century-long journey in pediatric and congenital heart care, featuring esteemed speakers.
Heart/Kidney Symposium
This program will explore the epidemiology, pathophysiology, and treatment strategies for three key areas in nephrology, including atherosclerotic vascular disease in advanced chronic kidney disease (CKD), atrial fibrillation in the context of advanced CKD, and hypertension and chronic kidney disease, with international experts discussing the latest developments in these areas.
QCOR at Sessions
The QCOR at Scientific Sessions 2024 is a 1-day program that will be of interest to clinicians, researchers, medical students and trainees, nurses, pharmacists, administrators, healthcare and managed care professionals, policymakers, and other professionals interested in the quality of care and outcomes research in cardiovascular disease and stroke. The program begins on Friday, November 15, 2024, at 8 a.m. and ends at 5 p.m.
International Symposium
This symposium will bring together AHA’s international partners and collaborators to:
- Learn about AHA’s 2nd Century priorities to improve cardiovascular and brain health internationally.
- Share global perspectives and opportunities to engage and find solutions through research, evidenced based quality care, and system-wide approaches for improved health from patient to population.
Late-Breaking Science
Leading researchers will reveal the results of high impact science from clinical registries, observational studies and randomized clinical trials.
Pre-Sessions Symposia and Early Career Day
Early Career
The AHA is committed to the next generation of clinicians and researchers by offering programs to facilitate your career growth and development. If you are a student, trainee, fellow, or early in your career, this is designed for you.
Congenital Heart Disease and Pediatric Cardiology Symposium
This program will focus on congenital and pediatric cardiology, including a showcase of distinguished AHA-supported congenital/pediatric cardiovascular researchers, preventive cardiology, including strategies for proactive practice change, closing gaps in care, and collaboration to prevent cardiovascular disease in children, and a reflection on the American Heart Association’s century-long journey in pediatric and congenital heart care, featuring esteemed speakers.
Heart/Kidney Symposium
This program will explore the epidemiology, pathophysiology, and treatment strategies for three key areas in nephrology, including atherosclerotic vascular disease in advanced chronic kidney disease (CKD), atrial fibrillation in the context of advanced CKD, and hypertension and chronic kidney disease, with international experts discussing the latest developments in these areas.
QCOR at Sessions
The QCOR at Scientific Sessions 2024 is a 1-day program that will be of interest to clinicians, researchers, medical students and trainees, nurses, pharmacists, administrators, healthcare and managed care professionals, policymakers, and other professionals interested in the quality of care and outcomes research in cardiovascular disease and stroke. The program begins on Friday, November 15, 2024, at 8 a.m. and ends at 5 p.m.
International Symposium
This symposium will bring together AHA’s international partners and collaborators to:
- Learn about AHA’s 2nd Century priorities to improve cardiovascular and brain health internationally.
- Share global perspectives and opportunities to engage and find solutions through research, evidenced based quality care, and system-wide approaches for improved health from patient to population.